The Binding of Aripiprazole to Plasma Proteins in Chronic Renal Failure Patients

The Binding of Aripiprazole to Plasma Proteins in Chronic Renal Failure Patients

The binding of drugs to plasma protein is frequently altered in certain types of renal diseases. We recently reported on the effects of oxidation and uremic toxins on the binding of aripiprazole (ARP) to human serum albumin. In our continuing investigations, we examined the binding of ARP to plasma...

Full description

Saved in:
Bibliographic Details
Main Authors: Kenshiro Hirata, Tokunori Ikeda, Hiroshi Watanabe, Toru Maruyama, Motoko Tanaka, Victor Tuan Giam Chuang, Yuji Uchida, Keiki Sakurama, Koji Nishi, Keishi Yamasaki, Masaki Otagiri
Format: article
Language:EN
Published: MDPI AG 2021
Subjects:
uremic toxins
indoxyl sulphate
renal disease
protein binding
aripiprazole
Medicine
R
Online Access:https://doaj.org/article/5521bd7ff6104aa1a466933dd37f6b68
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/5521bd7ff6104aa1a466933dd37f6b68

Similar Items